Please join us for the Taysha Gene Therapies Manufacturing Day on Tuesday, July 27th from 10:00 AM–1:00 PM EDT. Hear…
The webinar will feature a fireside chat with Key Opinion Leader (KOL) Jeffrey Miller, M.D. and CytoImmune's Co-Founder Michael Caligiuri, M.D.…
The webinar will feature a presentation by Key Opinion Leader (KOL) Mark Ryder, M.D. (University of California, San Francisco). On…
The webinar will feature a presentation by Key Opinion Leader (KOL) Ali Mostajelean M.D. (UCSF Benioff Children's Hospital Oakland) who…
Members of the Celyad Oncology leadership team will provide an overview of the recent breakthroughs in the R&D pipeline including…
Please join us for the Catalyst Biosciences R&D Day featuring a presentation by Key Opinion Leader (KOL) Filomeen Haerynck, M.D.,…
The webinar will feature: -Testimonial from a patient living with refractory ascites -Presentations by Key Opinion Leaders (KOLs) Hugo E.…
The webinar will feature presentations by two experts: Professor of Neurology Matthew Kiernan, PhD, DSc, FRACP, FAHMS, AM, MBBS and…
The webinar will feature a presentation by Key Opinion Leaders (KOLs) Jeremy Feldman, M.D. (Arizona Pulmonary Specialists) and Richard N.…

The event will feature presentations by the SCYNEXIS management team who will discuss its H2:2021 commercial launch plans for BREXAFEMME®…
Topics of discussion will include: -TSHA-104 (SURF1-associated Leigh syndrome): AAV9-based gene therapy with a transgene encoding the human SURF1 protein…
Topics of discussion will include: -TSHA-120 (GAN): Pivotal-stage AAV9 gene replacement therapy program for the treatment of giant axonal neuropathy…
The webinar will feature presentations by Key Opinion Leaders (KOLs) Steven Lin, M.D. (MD Anderson Cancer Center), and Trevor M.…
The webinar will feature a presentation by Sierra's management team to discuss recent data from the previously completed SIMPLIFY-1 and…
The webinar will feature a presentation by Key Opinion Leader (KOL) Richard Béliveau, Ph.D. (Université du Québec à Montréal) who…
Topics: - Opening Remarks - Company Overview - Harbour Mice®: Industry Leading Platform Technology Generating Fully Human Monoclonal Antibodies -…